On the Pathogenesis of Alzheimer's Disease: The MAM Hypothesis

被引:120
作者
Area-Gomez, Estela [1 ]
Schon, Eric A. [2 ]
机构
[1] Columbia Univ, Dept Neurol, New York, NY USA
[2] Columbia Univ, Dept Genet & Dev, New York, NY USA
基金
美国国家卫生研究院;
关键词
cholesterol; endoplasmic reticulum; lipid rafts; mitochondria; phospholipids; AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; ER MEMBRANES; MITOCHONDRIA; CHOLESTEROL; PRESENILIN-1; DOMAIN; APP;
D O I
10.1096/fj.201601309
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pathogenesis of Alzheimer's disease (AD) is currently unclear and is the subject of much debate. The most widely accepted hypothesis designed to explain AD pathogenesis is the amyloid cascade, which invokes the accumulation of extracellular plaques and intracellular tangles as playing a fundamental role in the course and progression of the disease. However, besides plaques and tangles, other biochemical and morphological features are also present in AD, often manifesting early in the course of the disease before the accumulation of plaques and tangles. These include altered calcium, cholesterol, and phospholipid metabolism; altered mitochondrial dynamics; and reduced bioenergetic function. Notably, these other features of AD are associated with functions localized to a subdomain of the endoplasmic reticulum (ER), known as mitochondria-associated ER membranes (MAMs). The MAM region of the ER is a lipid raft-like domain closely apposed to mitochondria in such a way that the 2 organelles are able to communicate with each other, both physically and biochemically, thereby facilitating the functions of this region. We have found that MAM-localized functions are increased significantly in cellular and animal models of AD and in cells from patients with AD in a manner consistent with the biochemical findings noted above. Based on these and other observations, we propose that increased ER-mitochondrial apposition and perturbed MAM function lie at the heart of AD pathogenesis.-Area-Gomez, E., Schon, E. A. On the pathogenesis of Alzheimer's disease: the MAM hypothesis.
引用
收藏
页码:864 / 867
页数:4
相关论文
共 50 条
[41]   Mitochondrial Toxic Effects of Aβ Through Mitofusins in the Early Pathogenesis of Alzheimer's Disease [J].
Wu, Zhaofei ;
Zhu, Yushan ;
Cao, Xingshui ;
Sun, Shufeng ;
Zhao, Baolu .
MOLECULAR NEUROBIOLOGY, 2014, 50 (03) :986-996
[42]   Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis [J].
Weidling, Ian W. ;
Swerdlow, Russell H. .
EXPERIMENTAL NEUROLOGY, 2020, 330
[43]   Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease [J].
Morris, Gary P. ;
Clark, Ian A. ;
Vissel, Bryce .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
[44]   A New Hypothesis for Alzheimer's Disease: The Lipid Invasion Model [J].
Rudge, Jonathan D'Arcy .
JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2022, 6 (01) :129-161
[45]   A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease [J].
Area-Gomez, Estela ;
de Groof, Ad ;
Bonilla, Eduardo ;
Montesinos, Jorge ;
Tanji, Kurenai ;
Boldogh, Istvan ;
Pon, Liza ;
Schon, Eric A. .
CELL DEATH & DISEASE, 2018, 9
[46]   Mitochondrial Cholesterol in Alzheimer's Disease and Niemann-Pick Type C Disease [J].
Torres, Sandra ;
Garcia-Ruiz, Carmen M. ;
Fernandez-Checa, Jose C. .
FRONTIERS IN NEUROLOGY, 2019, 10
[47]   ß-Site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis [J].
Tan, Jiangli ;
Evin, Genevieve .
JOURNAL OF NEUROCHEMISTRY, 2012, 120 (06) :869-880
[48]   Subcellular Injuries in Alzheimer's Disease [J].
Tillement, Jean-Paul ;
Papadopoulos, Vassilios .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (04) :593-605
[49]   Involvement of cholesterol in the pathogenesis of Alzheimer's disease: Role of statins [J].
Pregelj, Peter .
PSYCHIATRIA DANUBINA, 2008, 20 (02) :162-167
[50]   Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances [J].
Wang, Wenzhang ;
Zhao, Fanpeng ;
Ma, Xiaopin ;
Perry, George ;
Zhu, Xiongwei .
MOLECULAR NEURODEGENERATION, 2020, 15 (01)